© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
AiXin Life International, Inc. (AIXN) stock remained unchanged at $0.26 a share on OTC. The stock opened at $0.26, fluctuating between $0.26 to $0.65 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 08, 2026 | 0.26 | 0.26 | 0.26 | 0.26 | 281 |
| Jul 07, 2026 | 0.25 | 0.25 | 0.25 | 0.25 | 135 |
| Jul 01, 2026 | 0.32 | 0.32 | 0.32 | 0.32 | 392 |
| May 28, 2026 | 0.32 | 0.32 | 0.32 | 0.32 | 392 |
| May 18, 2026 | 0.65 | 0.65 | 0.65 | 0.65 | 181 |
| Apr 20, 2026 | 0.20 | 0.20 | 0.20 | 0.20 | 280 |
| Apr 14, 2026 | 0.25 | 0.25 | 0.25 | 0.25 | 176 |
| Apr 13, 2026 | 0.65 | 0.65 | 0.65 | 0.65 | 1 |
| Apr 09, 2026 | 0.22 | 0.26 | 0.22 | 0.26 | 560 |
| Apr 08, 2026 | 0.65 | 0.65 | 0.20 | 0.60 | 710 |
| Apr 06, 2026 | 0.52 | 0.52 | 0.52 | 0.52 | 1.03K |
| Mar 16, 2026 | 0.22 | 0.22 | 0.22 | 0.22 | 200 |
| Jan 22, 2026 | 0.17 | 0.17 | 0.17 | 0.17 | 3K |
| Dec 30, 2025 | 0.21 | 0.21 | 0.17 | 0.17 | 1K |
| Dec 15, 2025 | 0.16 | 0.16 | 0.16 | 0.16 | 100 |
| Nov 06, 2025 | 0.16 | 0.16 | 0.16 | 0.16 | 100 |
| Oct 22, 2025 | 0.68 | 0.68 | 0.68 | 0.68 | 186 |
| Oct 20, 2025 | 0.14 | 0.14 | 0.14 | 0.14 | 10 |
| Oct 07, 2025 | 0.60 | 0.60 | 0.60 | 0.60 | 100 |
| Oct 02, 2025 | 0.60 | 0.60 | 0.60 | 0.60 | 100 |
AiXin Life International, Inc. develops, manufactures, markets, and sells healthcare, nutritional products, and wellness supplements in the People's Republic of China. The company operates through four segments: Direct Sales, Pharmacy, Hotel, and Manufacture and Sale. It offers herbs, greens, and traditional Chinese remedies; and functional products, such as weight management tools, probiotics, and foods and drinks; and rhino king, colostrum powder derived from goat’s milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules. The company also engages in hotel business. It provides products manufactured by the company and purchased from third parties, as well as marketing and distribution services to other manufacturers and suppliers of healthcare products. The company sells its products through company-owned offices open to clients, pharmacies, direct marketing, e-commerce, exhibition events, conferences, and person-to-person marketing. The company is based in Chengdu, China.
| Employees | 116 |
| Beta | -3.02 |
| Sales or Revenue | $4.09M |
| 5Y Sales Change% | 13.265% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Distribution |